rs797045563
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PM4
The NM_007175.8(ERLIN2):c.1002_1007delGGCCAC(p.Ala335_Thr336del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,854 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T334T) has been classified as Likely benign.
Frequency
Consequence
NM_007175.8 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 18Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
- juvenile primary lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- recessive intellectual disability-motor dysfunction-multiple joint contractures syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERLIN2 | NM_007175.8 | c.1002_1007delGGCCAC | p.Ala335_Thr336del | disruptive_inframe_deletion | Exon 12 of 12 | ENST00000519638.3 | NP_009106.1 | |
| ERLIN2 | NM_001362878.2 | c.1002_1007delGGCCAC | p.Ala335_Thr336del | disruptive_inframe_deletion | Exon 12 of 12 | NP_001349807.1 | ||
| ERLIN2 | XM_047421307.1 | c.1002_1007delGGCCAC | p.Ala335_Thr336del | disruptive_inframe_deletion | Exon 13 of 13 | XP_047277263.1 | ||
| ERLIN2 | XM_047421308.1 | c.756_761delGGCCAC | p.Ala253_Thr254del | disruptive_inframe_deletion | Exon 9 of 9 | XP_047277264.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ERLIN2 | ENST00000519638.3 | c.1002_1007delGGCCAC | p.Ala335_Thr336del | disruptive_inframe_deletion | Exon 12 of 12 | 2 | NM_007175.8 | ENSP00000428112.1 | ||
| ERLIN2 | ENST00000521644.5 | c.1002_1007delGGCCAC | p.Ala335_Thr336del | disruptive_inframe_deletion | Exon 12 of 12 | 5 | ENSP00000429621.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251292 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461670Hom.: 0 AF XY: 0.00000963 AC XY: 7AN XY: 727146 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74340 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Spastic paraplegia Uncertain:1
ClinVar contains an entry for this variant (Variation ID: 210957). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with ERLIN2-related conditions. This variant is present in population databases (rs797045563, gnomAD 0.0009%). This variant, c.1002_1007del, results in the deletion of 2 amino acid(s) of the ERLIN2 protein (p.Ala335_Thr336del), but otherwise preserves the integrity of the reading frame. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at